Bicycle Therapeutics plc (FRA:50BA)
4.500
0.00 (0.00%)
At close: Mar 18, 2026
Bicycle Therapeutics Revenue
In the year 2025, Bicycle Therapeutics had annual revenue of $72.59M USD with 105.77% growth. Bicycle Therapeutics had revenue of $47.96M in the quarter ending December 31, 2025, with 1,193.28% growth.
Revenue
$72.59M
Revenue Growth
+105.77%
P/S Ratio
4.22
Revenue / Employee
$252.03K
Employees
288
Market Cap
260.78M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 72.59M | 37.31M | 105.77% |
| Dec 31, 2024 | 35.28M | 8.30M | 30.76% |
| Dec 31, 2023 | 26.98M | 12.51M | 86.52% |
| Dec 31, 2022 | 14.46M | 2.77M | 23.65% |
| Dec 31, 2021 | 11.70M | 1.31M | 12.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Biotest Aktiengesellschaft | 635.20M |
| 2invest AG | 28.07M |
| Darwin AG | 27.35M |
| Paion AG | 14.81M |
| co.don AG | 6.24M |
| MagForce AG | 1.08M |
| Biomark Diagnostics | 57.01K |
| bioXXmed AG | 20.49K |